Prenatal amphetamine exposure and birth outcomes: a systematic review and metaanalysis.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 21658669.
- Also identified by DOI 10.1016/j.ajog.2011.04.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this study was to systematically review the relationship between amphetamine exposure in pregnancy and birth outcomes. Electronic databases were searched to identify relevant studies. Data from included studies were extracted by 2 reviewers. Summary odds ratio (OR) and confidence intervals (CIs) were calculated using the random effects model. Ten studies were included. Significant increases in unadjusted risks of preterm birth (OR, 4.11; 95% CI, 3.05-5.55), low birthweight (OR, 3.97; 95% CI, 2.45-6.43), and small for gestational age (OR, 5.79; 95% CI, 1.39-24.06) were identified among women exposed to amphetamines in pregnancy. The mean birthweight was significantly lower among amphetamine-exposed pregnancies (mean difference, -279 g; 95% CI, -485 to -74 g). Two studies provided adjusted estimates on different outcomes, and their results were consistent with the findings from the unadjusted data. Amphetamine exposure in pregnancy is associated with adverse birth outcomes and should be identified by physicians providing antenatal care.
Medical subject headings
- Amphetamine
- Amphetamine-Related Disorders
- Maternal-Fetal Exchange
- Pregnancy Outcome